Assessment of Cardiovascular Risk in Hospitalized Patients with Hypertension Aged 40 and Over

1. US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute. Assessing Cardiovascular Risk – Systematic Evidence Review from the Risk Assessment Work Group. Bethesda; 2013. 139 p.Search in Google Scholar

2. Reiner Z, Catapano A, Backer GD, Gaham I, Taskinen MR, Wiclund O, et al. ESC/EAS Guidelines for the managemet of dyslipidaemias. Eur Heart J. 2011;32:1769-818.Search in Google Scholar

3. Lengelé JP, Vinck WJ, De Plaen JF, Persu A. Cardiovascular risk assessment in hypertensive patients: major discrepancy according to ESH and SCORE strategies. J Hypertens. 2007;25(4):757-62.10.1097/HJH.0b013e328017f6fa17351366Open DOISearch in Google Scholar

4. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281-357.10.1097/01.hjh.0000431740.32696.cc23817082Search in Google Scholar

5. Stoianov M. [Assessment of cardiovascular risk by SCORE]. Science Cardiology. 2010;3:142-7. Bulgarian.Search in Google Scholar

6. Erhardt L, Moller R, Puig JG. Comprehensive cardiovascular risk management – what does it mean in practice? Vasc Health and Risk Manag. 2007;3(5):587-603.Search in Google Scholar

7. Piepoli M, Hoes A, Agewall S, Albus S, Brotons C, Catapano A, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315-81.10.1093/eurheartj/ehw106498603027222591Search in Google Scholar

8. Wilkins E, Wilson L, Wickramasinghe K, Bhatnagar P, Rayner M, Townsend N. European Cardiovascular Disease Statistics. Brussels: European Heart Network; 2017. 192 p.Search in Google Scholar

9. National Center of Public Health and Analysis. [National Program on prevention and Control of Non-Communicable Diseases in Bulgaria (2014-2020)] [Internet]. Sofia; 2013 [cited 2017 Jun 6]. [about 46 p.]. Bulgarian. Available from: http://www.strategy.bg/StrategicDocuments/View.aspx?lang=bg-BG&Id=861.Search in Google Scholar

10. Scottish Intercollegiate Guidelines Network. Risk estimation and the prevention of cardiovascular disease (A National clinical Guideline) [Internet]. Edinburgh; 2007 [cited 2017 Jun 14]. Available from: http://www.sign.ac.uk/assets/sign97.pdfSearch in Google Scholar

11. Manolova A, Tsolova G, Grigorova-Petrova K, Gavrailova M, Dimitrov P, Petrova P. [Medical facts associated with physical activity – Project BG051PO001-5.3.3-0011C0001] [Internet]. 2011 [cited 2017 Jun 14]. Bulgarian. Available from: http://mpes.government.bg/Documents/PressCenter/News/nikoga_ne_kusno_22112011/Medical_facts.pdfSearch in Google Scholar

12. Ulusoy S. Assessment of cardiovascular risk in hypertensive patients: a comparasion of commonly used risk scoring programs. Kidney Int Suppl (2011). 2013;3(4):340-342.10.1038/kisup.2013.72408971225019017Search in Google Scholar

13. National Vascular Disease Prevention Alliance. Guidelines for the Management of Absolute Cardiovascular Disease Risk. National Stroke Foundation; 2012. 124. p.Search in Google Scholar

14. Paula EA, Paula RB, Costa DM, Colugnati FA, Paiva EP. Cardiovascular risk assessment in hypertensive patients. Rev Latino-Am Enfermagem. 2013;21(3):820-7.10.1590/S0104-1169201300030002323918030Search in Google Scholar

15. Yotov Y. [Assessment of Cardiovascular Risk for developing Ischemic Heart Disease in Women] [dissertation]. Varna: Medical University - Varna; 2007. Bulgarian.Search in Google Scholar

16. Hobbs FBR, Jukema JW, Da Silva PM, McCormack T, Catapano AL. Barriers to cardiovascular disease risk scoring and primary prevention in Europe. QJM. 2010;103(10):727-39.10.1093/qjmed/hcq12220685842Search in Google Scholar

17. Mortensen MB, Falk E. Limitation of the SCORE-guided European guidelines on cardiovascular disease prevention. Eur Heart J. 2017;38:2259-63.Search in Google Scholar